Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 42,126 | 11,688 | 226 | 130,145 | 14,854 |
| Cost of Goods | 4,657 | 4,058 | N/A | N/A | N/A |
| Gross Profit | 37,469 | 7,630 | 226 | 130,145 | 14,854 |
| Operating Expenses | 220,025 | 240,227 | 156,510 | 139,720 | 124,189 |
| Operating Income | -181,899 | -232,539 | -156,284 | -9,575 | -109,335 |
| Other Income | 631 | 1,865 | 0 | 0 | 0 |
| Pre-tax Income | -181,268 | -230,674 | -156,284 | -9,575 | -109,335 |
| Income Tax | 951 | 6,364 | N/A | N/A | N/A |
| Net Income Continuous | -182,219 | -237,038 | -156,284 | -9,575 | -109,335 |
| Net Income | $-182,219 | $-237,038 | $-156,284 | $-9,575 | $-109,335 |
| EPS Basic Total Ops | -5.34 | -7.46 | -4.92 | -0.30 | N/A |
| EPS Basic Continuous Ops | -5.34 | -7.46 | -4.92 | -0.30 | N/A |
| EPS Diluted Total Ops | -5.34 | -7.46 | -4.92 | -0.30 | N/A |
| EPS Diluted Continuous Ops | -5.34 | -7.46 | -4.92 | -0.30 | N/A |
| EBITDA(a) | $-178,910 | $-229,265 | $-153,631 | $-6,324 | $-105,491 |